-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2020 to Q3 2025.
- Propanc Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$164K, a 158% decline year-over-year.
- Propanc Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$1.75M, a 221% decline year-over-year.
- Propanc Biopharma, Inc. annual Nonoperating Income (Expense) for 2025 was -$1.65M, a 298% decline from 2024.
- Propanc Biopharma, Inc. annual Nonoperating Income (Expense) for 2024 was -$414K, a 59.2% increase from 2023.
- Propanc Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.01M, a 40.4% decline from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)